These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34006261)

  • 1. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.
    Taş Ozyurtseven B; Serin I; Nursal AF; Pehlivan S; Pehlivan M
    BMC Oral Health; 2021 May; 21(1):272. PubMed ID: 34006261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
    Guo Z; Cui W; Que L; Li C; Tang X; Liu J
    Int J Oral Maxillofac Surg; 2020 Mar; 49(3):298-309. PubMed ID: 31445964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
    Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
    Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population based study of multiple myeloma patients with medication-related osteonecrosis of the jaw.
    Auzina D; Slaidina A; Sevastjanova M; Erts R; Lejnieks A; Lejniece S
    Stomatologija; 2019; 21(1):13-17. PubMed ID: 31619658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
    Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
    J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of bisphosphonates on the bone and its surrounding tissues: mechanistic insights into medication-related osteonecrosis of the jaw.
    Srivichit B; Thonusin C; Chattipakorn N; Chattipakorn SC
    Arch Toxicol; 2022 May; 96(5):1227-1255. PubMed ID: 35199244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prevention of Medication-related Osteonecrosis of the Jaw.
    Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
    Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
    Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
    Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma and chemical maxillary osteonecrosis. Can both occur simultaneously?
    Junquera S; Álvarez-Yagüe E; Junquera L; Ugalde R; Rúa L
    J Stomatol Oral Maxillofac Surg; 2020 Nov; 121(5):523-526. PubMed ID: 31863926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases.
    Otto S; Pautke C; Van den Wyngaert T; Niepel D; Schiødt M
    Cancer Treat Rev; 2018 Sep; 69():177-187. PubMed ID: 30055439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws.
    Pan J; Liu JY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Jun; 39(3):245-254. PubMed ID: 34041871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
    Kuroshima S; Sasaki M; Murata H; Sawase T
    Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors.
    Dodson TB
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Study of Oral Health Parameters and the Properties and Composition of Saliva in Oncological Patients with and without Medication-Related Osteonecrosis of the Jaw Who Take Bisphosphonates.
    Sobczak-Jaskow H; Kochańska B; Drogoszewska B
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374277
    [No Abstract]   [Full Text] [Related]  

  • 16. Does medication-related osteonecrosis of the jaw affect survival of patients with Multiple Myeloma?: Exploring a large single center database using artificial intelligence.
    Bittrich M; Hetterich R; Solimando AG; Krebs M; Loda S; Danhof S; Anton S; Zhou X; Kerscher A; Beilhack A; Kortüm KM; Rasche L; Einsele H; Knop S; Hartmann S
    Clin Exp Med; 2023 Dec; 23(8):5215-5226. PubMed ID: 37805620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma identified within the same site of the mandible with medication-related osteonecrosis of jaw: An unusual case report.
    Wu XH; Chen SW
    Medicine (Baltimore); 2023 Jul; 102(29):e34260. PubMed ID: 37478232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma.
    Lu SY; Ma MC; Wang MC; Hsue SS
    J Formos Med Assoc; 2021 Nov; 120(11):1967-1976. PubMed ID: 33551311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB; O'Ryan F
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.